Mutational Analysis of Mitochondrial tRNA Genes in Patients with Asthma
Background: Mitochondria are autonomous cellular organelles that oversee a variety of functions such as metabolism, energy production, calcium buffering, and cell fate determination. Most recently, mitochondrial dysfunction caused by mitochondrial mutations played important roles in the pathogenesis of asthma. However, the frequency of mitochondrial tRNA mutations in asthma is largely unknown.
Methods: Overall, 200 patients with asthma and 100 healthy control subjects were recruited between Jan 2015 and Dec 2015 at the Guangming New District People's Hospital, Shenzhen, Guangdong Province, China. We first performed PCR amplification of the mitochondrial tRNA genes and subsequently sequenced the PCR products, and we used the pathogenicity scoring system to evaluate the potential role of these mutations.
Results: Two patients carrying the tRNAThr G15927A mutation, three patients carrying the tRNAAla T5655C mutation and one patient carrying the tRNAGlu A14693G mutation, these mutations were absent in healthy controls. Moreover, these mutations located at positions highly conserved between different species, and may cause a failure in mitochondrial tRNA metabolism, consequently result in mitochondrial dysfunction that responsible for asthma. In addition, the pathogenicity scoring system showed that these mutations should be regarded as “pathogenic”.
Conclusion: Mitochondrial tRNA mutations caused the mitochondrial dysfunction may be involved in the pathogenesis of asthma. Thus, this study provided novel insight into the molecular mechanism underlying mitochondrial tRNA mutations in asthma. Moreover, screening for the mitochondrial tRNA mutations was advised for the diagnosis of patients with asthma.
Borish L, Culp JA (2008). Asthma: a syndrome composed of heterogeneous diseases. Ann Allergy Asthma Immunol, 101(1): 1-8.
Kurukulaaratchy RJ, Matthews S, Arshad SH (2006). Relationship between childhood atopy and wheeze: what mediates wheezing in atopic phenotypes? Ann Allergy Asthma Immunol, 97(1): 84-91.
Lim RH, Kobzik L, Dahl M (2010). Risk for asthma in offspring of asthmatic mothers versus fathers: a meta-analysis. PLoS One, 5(4): e10134.
Ding Y, Leng J, Fan F, Xia B, Xu P (2013). The role of mitochondrial DNA mutations in hearing loss. Biochem Genet, 51(7-8): 588-602.
Meyerson C, Van Stavern G, McClelland C (2015). Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol, 9:1165-1176.
Ryan JJ, Archer SL (2015). Emerging con-cepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension. Circulation, 131(19):1691-702.
Raby BA, Klanderman B, Murphy A, Mazza S, Camargo CA Jr, Silverman EK, Weiss ST (2007). A common mitochondrial haplogroup is associated with elevated total serum IgE levels. J Allergy Clin Immunol, 120(2):351-358.
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999). Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet, 23(2):147.
McFarland R, Elson JL, Taylor RW, Howell N, Turnbull DM (2004). Assigning pathogenicity to mitochondrial tRNA mutations: when ‘‘definitely maybe’’ is not good enough. Trends Genet, 20(12): 591-6.
Yarham JW, Al-Dosary M, Blakely EL, Alston CL, Taylor RW, Elson JL, McFarland R (2011). A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations. Hum Mutat, 32(11):1319-1325.
Vercelli D (2008). Discovering susceptibility genes for asthma and allergy. Nat Rev Im-munol, 8(3):169-182.
Henricks PA, Nijkamp FP (2001). Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther, 14(6): 409-420.
Brandon MC, Lott MT, Nguyen KC, Spolim S, Navathe SB, Baldi P, Wallace DC (2005). MITOMAP: A human mitochondrial genome database–2004 update. Nucleic Acids Res, 33 (Database issue):D611-3.
Zifa E, Daniil Z, Skoumi E, et al (2012). Mitochondrial genetic background plays a role in increasing risk to asthma. Mol Biol Rep, 39(4): 4697-708.
Florentz C, Sohm B, Tryoen-Toth P, Putz J, Sissler M (2003). Human mitochondrial tRNAs in health and disease. Cell Mol Life Sci, 60(7):1356-75.
Sprinzl M, Horn C, Brown M, Ioudovitch Steinberg S (1998). Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res, 26(1):148-153.
Wang X, Lu J, Zhu Y et al (2008). Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families. Pharmacogenet Genomics, 18(12):1059-70.
Normanly J, Abelson J (1989). tRNA identity. Annu Rev Biochem, 58: 1029-1049.
Li X, Fischel-Ghodsian N, Schwartz F, Yan Q, Friedman RA, Guan MX (2004). Bio-chemical characterization of the mitochondrial tRNASer(UCN) T7511C mutation associated with nonsyndromic deafness. Nucleic Acids Res, 32(3): 867-77.
Tzen CY, Thajeb P, Wu TY, Chen SC (2003). MELAS with point mutations involving tRNALeu (A3243G) and tRNAGlu A14693G. Muscle Nerve, 28(5): 575-81.
Ding Y, Li Y, You J, Yang L, Chen B, Lu J, Guan MX (2009). Mitochondrial tRNA(Glu) A14693G variant may modulate the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation in a Han Chinese family. J Genet Genomics, 36(4): 241-250.
Brulé H, Holmes WM, Keith G, Giegé R, Florentz C (1998). Effect of a mutation in the anticodon of human mitochondrial tRNAPro on its post-tran¬scriptional modification pattern. Nucleic Acids Res, 26(2): 537-543.
|Issue||Vol 46 No 5 (2017)|
|Asthma Children Mitochondrial tRNA Mutation Pathogenicity China|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|